MT-RNR1

Aminoglycoside-induced sensorineural hearing loss

1 article(s) in the watch · Pharmacogenomics

Curated publications

MT-RNR1 genotype testing for preventing aminoglycoside-mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)

Aminoglycoside-induced sensorineural hearing loss

PGx4 August 2026

External references

OMIM ↗GeneReviews ↗ClinVar ↗NCBI Gene ↗

Automatic aggregation page — a clinical introduction may be added.